Last update 01 Nov 2024

FGFRs x VEGFR2 x M-CSF

Basic Info

Related Targets
FGFRsVEGFR2M-CSF

Related

1
Drugs associated with FGFRs x VEGFR2 x M-CSF
Simmitinib
Target
FGFRs x M-CSF x VEGFR2
Mechanism
FGFRs antagonists [+2]
Active Org.
Shanghai Runshi Pharmaceutical Technology Co., Ltd. [+2]
Originator Org.
Shanghai Institute of Materia Medica Chinese Academy of SciShanghai Institute of Materia Medica Chinese Academy of Sci
Active Indication
Metastatic Esophageal Squamous Cell Carcinoma [+14]
Inactive Indication
Transitional Cell Carcinoma
Drug Highest PhasePhase 3
First Approval Ctry. / Loc.-
First Approval Date20 Jan 1800
12
Clinical Trials associated with FGFRs x VEGFR2 x M-CSF
NCT06656091 / Not yet recruitingPhase 3
Simmitinib Versus Investigator's Choice of Chemotherapy for Participants With Advanced or Metastatic Oesophageal Squamous Cell Carcinoma : a Randomised, Open-label, Multicentre, Phase 3 Study
ChiCTR2400089300 / SuspendedPhase 1IIT
An open-label and multicenter Phase ? Clinical Study to Evaluate the Safety and Efficacy of SYS6010 in combination with Enlonstobart and Simmitinib in patients with advanced esophageal cancer
100 Clinical Results associated with FGFRs x VEGFR2 x M-CSF
Login to view more data
100 Translational Medicine associated with FGFRs x VEGFR2 x M-CSF
Login to view more data
0 Patents (Medical) associated with FGFRs x VEGFR2 x M-CSF
Login to view more data

Analysis

Perform a panoramic analysis of this field.
login
or
view full example data
Perform a panoramic analysis of this field.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free